CANDEL THERAPEUTICS INC (CADL)
US1374041093 - Common Stock
ChartMill assigns a Buy % Consensus number of 83% to CADL. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 11.22. This target is 70% above the current price.
CADL was analyzed by 7 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about CADL.
In the previous month the buy percentage consensus was at a similar level.
CADL was analyzed by 7 analysts. More opinions would make the average more meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2024-11-18 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-11-13 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-05-22 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2023-05-15 | BMO Capital | Maintains | Outperform -> Outperform |
| 2023-03-31 | Credit Suisse | Maintains | Outperform |
| 2022-12-07 | Credit Suisse | Maintains | Outperform |
| 2022-12-02 | HC Wainwright & Co. | Initiate | Buy |
| 2021-11-19 | BMO Capital | Initiate | Outperform |
| 2021-08-23 | UBS | Initiate | Buy |
| 2021-08-23 | Credit Suisse | Initiate | Outperform |
| 2021-08-23 | Jefferies | Initiate | Buy |